Inotiv

Inotiv is a leading provider of preclinical and clinical research services, dedicated to advancing the development of innovative therapeutics. With a strong commitment to scientific excellence, Inotiv supports pharmaceutical and biotechnology companies in their quest to bring new drugs to market.

Founded on the principles of integrity and collaboration, Inotiv offers a comprehensive range of services that include:

• Pharmacology: Conducting studies to evaluate the efficacy and safety of drug candidates.
• Toxicology: Assessing the potential adverse effects of compounds through rigorous testing.
• Pathology: Providing expert histopathological analysis to support regulatory submissions.
• Bioanalytical Services: Delivering precise and reliable data for pharmacokinetic and biomarker studies.

Headquartered in the UK, Inotiv operates state-of-the-art facilities equipped with cutting-edge technology. The company prides itself on its team of highly skilled scientists and researchers who are passionate about improving patient outcomes.

Inotiv’s vision is to be a trusted partner in the drug development process, ensuring that clients receive the highest quality data and insights. By fostering strong relationships with clients, Inotiv aims to accelerate the timeline for bringing new therapies to patients in need.

With a focus on innovation and continuous improvement, Inotiv is committed to staying at the forefront of scientific advancements. The company actively engages in research collaborations and partnerships to enhance its service offerings and expand its capabilities.

Inotiv is not just a service provider; it is a partner in the journey towards medical breakthroughs, dedicated to making a meaningful impact on global health.